drugset / Trial / NCT00504335
Safety and Pharmacokinetic Study of BIO 300 Capsules
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This trial is designed to evaluate the safety and pharmacokinetics of BIO 300 capsules when administered orally to healthy male and female volunteers. BIO 300 is expected to be safe for use starting at 500 mg.
Timeline
- Start
- 2007-06
- Primary completion
- 2007-09
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Genistein | Other / unclassified | 500 mg | Oral |
| Subject | Genistein | Other / unclassified | 1000 mg | Oral |
| Subject | Genistein | Other / unclassified | 1500 mg | Oral |
| Subject | Genistein | Other / unclassified | 2000 mg | Oral |